Oligohydramnios clinical trials
The registry lists 25 studies for Oligohydramnios across more than 10 countries. 5 are recruiting or about to start. 19 of them are mainly about Oligohydramnios (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-30.
Get an email when these change. Save the Oligohydramnios studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Otsuka Pharmaceutical Development & Commercialization, Inc. (2) · Woman's Health University Hospital, Egypt (2) · Kayseri Education and Research Hospital (2) · Zagazig University (1) · Benha University (1) · Deepecho (1) · University of Modena and Reggio Emilia (1) · Western Galilee Hospital-Nahariya (1)
What is being tested here
Drugs under test in Oligohydramnios studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The study
- Jan 2027Effect of LMWH on Neonatal Outcomes in Isolated Oligohydramnios · PAEC General Hospital, Islamabad
Who these studies take
Of the 5 Oligohydramnios studies recruiting now, 0 (0%) set no upper age limit and 5 (100%) stop at 75 or younger. 2 (40%) take children under 18. 4 (80%) are for women only and 0 (0%) for men only; 3 (60%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 1 (20%) | 1 (20%) |
| 18 | 4 (80%) | 1 (20%) |
| 30 | 4 (80%) | 0 (0%) |
| 40 | 3 (60%) | 0 (0%) |
| 50 | 1 (20%) | 0 (0%) |
| 65 | 0 (0%) | 0 (0%) |
| 75 | 0 (0%) | 0 (0%) |
| 85 | 0 (0%) | 0 (0%) |
Across all 25 studies, recruiting or not: 72% stop at 75 or younger and 72% at 65; 16% take children; 88% are for women only and 0% for men only; 48% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
What changed recently
From the registry's own updates since Oct 13, 2026.
Newly registered1
- Effect of LMWH on Neonatal Outcomes in Isolated OligohydramniosOct 30, 2026NCT07907731
Studies
Recruiting first, then most recently updated. Showing 25 of 25. search them.
- Effect of LMWH on Neonatal Outcomes in Isolated OligohydramniosRecruitingNCT07907731Phase 41 country
- A Study to See if Tolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days to Less Than 18 Years Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD)RecruitingNCT04782258Phase 36 countries
- PPROM Registry (Preterm Premature Rupture of Membranes)RecruitingNCT029973451 country
- Comparison Between Treatments of OligohydramniosRecruitingNCT07135037Phase 21 country
- "Fetal gRowth AbnorMality dEtection Trial"RecruitingNCT05043753Not applicable1 country
- A Study to See if Tolvaptan Can Delay Dialysis in Infants and Children Who at Enrollment Are 28 Days to Less Than 12 Weeks Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD)WithdrawnNCT04786574Phase 3
- Dilapan-S®: A Multicenter US E-registryActive, not recruitingNCT044511091 country
- The Effect of Oral Hypotonic Hydration in Isolated OligohydramniosCompletedNCT05332015Not applicable1 country
- Isolated Oligohydramnios Less Favorable Delivery and Neonatal OutcomesCompletedNCT055599571 country
- Developing and Testing AI Models for Fetal Biometry and Amniotic Volume Assessment in Fetal Ultrasound Scans.CompletedNCT050590931 country
- Effect of Intermittent Pneumatic Compression Device of Lower Limbs in OligohydramniosStatus unknownNCT05474326Not applicable
- The Added Contribution of Transvaginal Sonographic Evaluation of Amniotic Fluid IndexCompletedNCT039356071 country
- The Role of Zamzam Water in Idiopathic OligohydramniosStatus unknownNCT04684680Not applicable1 country
- Warfarine in Unexplained OligohydramniosTerminatedNCT01569035Phase 41 country
- Role of Antioxidants in Unexplained Oligohydramnios,A Randomized TrialCompletedNCT01990690Phase 41 country
- Hydrotherapy for the Reversal of OligohydramniosTerminatedNCT01682928Not applicable1 country
- Low Sodium Diet in Oligohydramnios Assigned for Conservative ManagementStatus unknownNCT03815968Not applicable1 country
- Coffee Consumption and PregnancyCompletedNCT03798275Not applicable1 country
- Does Amniotic Fluid Index Affect the Fetal Cardiac Performance?Status unknownNCT032774171 country
- Fetal Renal Artery Doppler Indices in Borderline Isolated OligohydramniosStatus unknownNCT029013401 country
- Nitric Oxide Donors for Treatment of Isolated OligohydramniosCompletedNCT02712125Phase 2/3
- Active Induction of Labor in Pregnancies Complicated With Oligohydramnios at TermCompletedNCT02581774
- Alterations of the Uteroplacental and Fetal Pulmonary Circulation Following AmnioinfusionStatus unknownNCT01258725Phase 11 country
- Foley Catheter Versus Vaginal Misoprostol for Cervical Ripening and Induction of LaborCompletedNCT01140971Not applicable1 country
- Amnioinfusion InitiativeStatus unknownNCT00787163Phase 31 country